{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:57:56Z","timestamp":1764403076920},"reference-count":79,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJGPT"],"published-print":{"date-parts":[[2021,5,5]]},"DOI":"10.4292\/wjgpt.v12.i3.40","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T05:57:12Z","timestamp":1619762232000},"page":"40-55","source":"Crossref","is-referenced-by-count":5,"title":["Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence?"],"prefix":"10.4292","volume":"12","author":[{"given":"Matheus William","family":"Becker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin Hepp","family":"Schwambach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Lunardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine Raquel","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2008.11.009"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2015.11.008"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00267"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34857"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.006"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050714"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010014"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.006"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020224"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22895"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.09.011"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04320.x"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12880"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2016.1127756"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.127.1103"},{"key":"B16","unstructured":"Gu J, Tang SJ, Tan SY, Wu Q, Zhang X, Liu CX, Gao XS, Yuan BD, Han LJ, Gao AP, Wu MY, Huang LH, Ma J, Xiao HP. An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury. Int J Clin Exp Med 2015; 8: 4320-4327"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-015-0861-7"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.08.018"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.6774"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163675"},{"key":"B21","unstructured":"Lunardelli MJM, Becker MW, Blatt CR. Hepatite medicamentosa: qual o papel do farmac\u00eautico cl\u00ednico? Rev Bras Farm Hosp Serv Sa\u00fade 2016; 4: 31-35"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7604939"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2019.09.003"},{"key":"B24","unstructured":"Heinrich MM. Fatores associados \u00e0s rea\u00e7\u00f5es adversas no tratamento da tuberculose no munic\u00edpio de Dourados\/MS. MsC. In: Escola Nacional de Sa\u00fade P\u00fablica Sergio Arouca 2014 [cited 20 March 2021]. Available from: https:\/\/www.arca.fiocruz.br\/handle\/icict\/22853"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2012.01368.x"},{"key":"B26","unstructured":"Magalh\u00e3es MP. S\u00e9rie de casos de hepatotoxicidade induzida por medicamentos, insumos vegetais e suplementos alimentares em pacientes de hospital universit\u00e1rio em Salvador \u2013 Bahia (Brasil). In: Universidade Federal da Bahia 2015 [cited 20 March 2021]. Available from: http:\/\/repositorio.ufba.br\/ri\/handle\/ri\/18587"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-2803.201900000-73"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1375953"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0214-RA"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.09.016"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04674.x"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.1.5.695"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-695X2010005000031"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.08.011"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3627"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23317"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0782"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200206-626OC"},{"key":"B39","unstructured":"Marra F, Marra CA, Bruchet N, Richardson K, Moadebi S, Elwood RK, Fitzgerald JM. Adverse drug reactions associated with first-line anti-tuberculosis drug regimens. Int J Tuberc Lung Dis 2007; 11: 868-875"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027610"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2014.03.006"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.03.006"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-282x2001000100016"},{"key":"B44","unstructured":"de Castro L, do Brasil PE, Monteiro TP, Rolla VC. Can hepatitis B virus infection predict tuberculosis treatment liver toxicity? Int J Tuberc Lung Dis 2010; 14: 332-340"},{"key":"B45","doi-asserted-by":"crossref","unstructured":"Nader LA, de Mattos AA, Picon PD, Bassanesi SL, De Mattos AZ, Pineiro Rodriguez M. Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: is anti-HCV a risk factor? Ann Hepatol 2010; 9: 70-74","DOI":"10.1016\/S1665-2681(19)31682-5"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.09.148"},{"key":"B47","unstructured":"Tovo CV, Souza ARd, Santos DEd, Mattos AZd, Mattos AAd, Santos BR. Avalia\u00e7\u00e3o da hepatotoxicidade dos anti-retrovirais na co-infec\u00e7\u00e3o VHC\/HIV. Rev Amrigs 2006; 50: 217-221"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1590\/s1516-31802007000400002"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-72032008000100004"},{"key":"B50","doi-asserted-by":"crossref","unstructured":"P\u00e9rez Gutthann S, Garc\u00eda Rodr\u00edguez LA. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology 1993; 4: 496-501","DOI":"10.1097\/00001648-199311000-00004"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02133.x"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1590\/s0074-02762011000600011"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0645"},{"key":"B54","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Rodr\u00edguez LA, Ruig\u00f3mez A, Jick H. A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy 1997; 17: 721-728","DOI":"10.1002\/j.1875-9114.1997.tb03747.x"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.5012"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.1.74"},{"key":"B57","unstructured":"Brasil. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Manejo da Infec\u00e7\u00e3o pelo HIV em Adultos. In: Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis, do HIV\/Aids e das Hepatites Virais. Bras\u00edlia 2018 [cited 20 March 2021]. Available from: http:\/\/www.aids.gov.br\/pt-br\/pub\/2013\/protocolo-clinico-e-diretrizes-terapeuticas-para-manejo-da-infeccao-pelo-hiv-em-adultos"},{"key":"B58","unstructured":"Brasil. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil. In: Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. \u2013 Bras\u00edlia: Minist\u00e9rio da Sa\u00fade, 2019 [cited 20 March 2021]. Available from: http:\/\/www.aids.gov.br\/pt-br\/pub\/2019\/manual-de-recomendacoes-para-o-controle-da-tuberculose-no-brasil"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1590\/S0482-50042011000200004"},{"key":"B60","unstructured":"Santiago Garc\u00eda D, Saturansky E, Poncino D, Ortiz V, Mart\u00ednez Artola Y, Rosenberg S, Abritta G, Palermo C, Enriquez N, Cravero A. [Liver diseases in rheumatoid and psoriatic arthritis]. Acta Gastroenterol Latinoam 2012; 42: 112-119"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-198904000-00003"},{"key":"B62","unstructured":"Propylthiouracil 2012"},{"key":"B63","unstructured":"Santos FAI. Preval\u00eancia da Hepatotoxicidade por Quimioterapia Pr\u00e9-operat\u00f3ria e Correla\u00e7\u00e3o com a Morbidade das Hepatectomias no C\u00e2ncer Colorretal Metast\u00e1tico. Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre 2013 [cited 20 March 2021]. Available from: https:\/\/docplayer.com.br\/6699757-Prevalencia-da-hepatotoxicidade-por-quimioterapia-pre-operatoria-e-correlacao-com-a-morbidade-das-hepatectomias-no-cancer-colorretal-metastatico.html"},{"key":"B64","doi-asserted-by":"crossref","unstructured":"Brito TC, Possuelo LG, Valim ARM, Todendi PF, Ribeiro AW, Gregianini TS, Jarczewski CA, Hutz MH, Rossetti MLR, Zaha A. Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity. An Acad Bras Cienc 2014; 86: 855-865","DOI":"10.1590\/0001-3765201420130350"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1590\/s0102-311x2012000400009"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-35862002000400003"},{"key":"B67","unstructured":"Szklo A, Mello FC, Guerra RL, Dorman SE, Muzy-de-Souza GR, Conde MB. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury. Int J Tuberc Lung Dis 2007; 11: 775-780"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.04.011"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260319"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3603"},{"key":"B72","doi-asserted-by":"crossref","unstructured":"Castelo Filho A, Kritski AL, Barreto \u00c2W, Lemos ACM, Netto AR, Guimar\u00e3es CA. II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose 2004. J Bras Pneumol 2004; 30: S57-S86","DOI":"10.1590\/S1806-37132004000700002"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1590\/s0037-86822010000600004"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i12.3327"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x1998001200005"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1590\/s1516-31802005000500004"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.5604\/16652681.1171778"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1590\/S1806-37132008001200010"},{"key":"B79","unstructured":"de Souza AF, de Oliveira e Silva A, Baldi J, de Souza TN, Rizzo PM. [Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis]. Arq Gastroenterol 1996; 33: 194-200"}],"container-title":["World Journal of Gastrointestinal Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2150-5349\/full\/v12\/i3\/40.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T01:33:13Z","timestamp":1698975193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2150-5349\/full\/v12\/i3\/40.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":79,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4292\/wjgpt.v12.i3.40","relation":{},"ISSN":["2150-5349"],"issn-type":[{"value":"2150-5349","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,5]]}}}